The Patent Finder

Clarassance, Inc.

Also on record
Records under this name other than the patents Clarassance, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Clarassance, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,957,018Recombinant Human CC10 Protein for Treatment of Influenza
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,394,349Modification and Compositions of Human Secretoglobin Proteins
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,122,344Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
Formerly held
Term ended
Term ended Sep 22, 2017 · USPTO record
Term endedTerm ended Sep 22, 2017USPTO record
US 6,255,281Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Formerly held
Term ended
Term ended May 28, 2017 · USPTO record
Term endedTerm ended May 28, 2017USPTO record
US 7,846,899Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
Formerly held
Term ended
Term ended May 28, 2017 · USPTO record
Term endedTerm ended May 28, 2017USPTO record
US 8,470,767Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
Term ended
Term ended May 28, 2017 · USPTO record
Term endedTerm ended May 28, 2017USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited